⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27629632 | 0.74 | — | — | |
| SCHEMBL3110384 | 0.74 | — | — | |
| SCHEMBL357742 | 0.74 | — | — | |
| SCHEMBL17184812 | 0.69 | HCAR2 (0.44) | — | |
| SCHEMBL30292849 | 0.69 | — | — | |
| SCHEMBL16030179 | 0.68 | FBP1 (0.38) | — | |
| SCHEMBL6866822 | 0.67 | F2RL1 (0.31) | — | |
| SCHEMBL9114090 | 0.66 | — | — | |
| SCHEMBL15067505 | 0.65 | — | — | |
| SCHEMBL14480207 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 425 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11897891-B2 | Tricyclic heterocycles as FGFR inhibitors | INCYTE CORPORATION (US) | 2024-02-13 | — | — | US | claimed |
| EP-3331959-B1 | ANIONIC CURABLE COMPOSITIONS | DESIGNER MOLECULES INC (US) | 2022-10-05 | — | — | EP | claimed |
| US-20220204696-A1 | PHENOLIC FUNCTIONALIZED POLYIMIDES AND COMPOSITIONS THEREOF | DESIGNER MOLECULES, INC | 2022-06-30 | — | — | US | claimed |
| US-20210171535-A1 | TRICYCLIC HETEROCYCLES AS FGFR INHIBITORS | INCYTE CORPORATION | 2021-06-10 | — | — | US | claimed |
| WO-2021113479-A1 | TRICYCLIC HETEROCYCLES AS FGFR INHIBITORS | INCYTE CORPORATION (US) | 2021-06-10 | — | — | WO | claimed |
| CN-108291122-B | Anionically curable compositions | 设计分子有限公司 | 2021-01-05 | — | — | CN | claimed |
| WO-2020219852-A1 | PHENOLIC FUNCTIONALIZED POLYIMIDES AND COMPOSITIONS THEREOF | DESIGNER MOLECULES, INC. (US) | 2020-10-29 | — | — | WO | claimed |
| US-20180237668-A1 | ANIONIC CURABLE COMPOSITIONS | DESIGNER MOLECULES, INC. | 2018-08-23 | — | — | US | claimed |
| EP-3331959-A1 | ANIONIC CURABLE COMPOSITIONS | Designer Molecules, Inc. (US) | 2018-06-13 | — | — | EP | claimed |
| WO-2017027482-A1 | ANIONIC CURABLE COMPOSITIONS | DESIGNER MOLECULES, INC. (US) | 2017-02-16 | — | — | WO | claimed |
| CN-102971317-A | Tetrahydro-pyrido-pyrimidine derivatives | NOVARTIS AG | 2013-03-13 | — | — | CN | claimed |
| CN-1082952-C | Pyrrolylpiperazinylphenyl oxazolidinone antimicrobials | UPJOHN CO (US) | 2002-04-17 | — | — | CN | claimed |
| CN-1206410-A | Azolyl piperazinyl phenyl oxazolidinone antimicrobials | UPJOHN CO (US) | 1999-01-27 | — | — | CN | claimed |
| US-20260071103-A1 | Anionic Curable Compositions | DESIGNER MOLECULES INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260071104-A1 | Anionic Curable Compositions | DESIGNER MOLECULES INC (US) | 2026-03-12 | — | — | US | disclosed |
| EP-4704846-A2 | NOVEL ERGOLINES AND METHODS OF TREATING MOOD DISORDERS | Gilgamesh Pharmaceuticals, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| US-4255423-A | BACTERICIDES | MERCK & CO., INC. (US) | 1981-03-10 | — | — | US | disclosed |
| US-4035395-A | Process for the preparation of ketones | BAYER AKTIENGESELLSCHAFT (DT) | 1977-07-12 | — | — | US | disclosed |
| US-4017313-A | Photosensitive composition containing a leuco dye, a photosensitizer, an aromatic aldehyde and a secondary or tertiary amine and the use thereof in a direct-print process | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
| US-4014889-A | Process for preparing ketones | BAYER AKTIENGESELLSCHAFT (DT) | 1977-03-29 | — | — | US | disclosed |